Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Xilio Therapeutics, Inc. (XLO)

Compare
0.7002
-0.0310
(-4.24%)
At close: April 3 at 4:00:01 PM EDT
0.7396
+0.04
+(5.63%)
Pre-Market: 4:01:10 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
6,344
6,344
--
--
--
Operating Expense
65,989
65,989
--
89,149
75,044
Operating Income
-59,645
-59,645
--
-89,149
-75,044
Other Income Expense
1,404
1,404
--
927
-756
Pretax Income
-58,241
-58,241
--
-88,222
-75,800
Net Income Common Stockholders
-58,241
-58,241
--
-88,222
-75,800
Diluted NI Available to Com Stockholders
-58,241
-58,241
--
-88,222
-75,800
Basic EPS
-1.55
-1.09
-2.78
-3.22
-13.52
Diluted EPS
-1.55
-1.09
-2.78
-3.22
-13.52
Basic Average Shares
44,211.5230
53,511.4240
27,496.1070
27,392.0870
5,606.3080
Diluted Average Shares
44,211.5230
53,511.4240
27,496.1070
27,392.0870
5,606.3080
Total Operating Income as Reported
-60,582
-60,582
--
-89,149
-75,044
Total Expenses
65,989
65,989
--
89,149
75,044
Net Income from Continuing & Discontinued Operation
-58,241
-58,241
--
-88,222
-75,800
Normalized Income
-57,304
-57,304
--
-88,222
-75,800
EBIT
-59,645
-59,645
--
-89,149
-75,044
EBITDA
-58,001
-58,001
--
-87,302
-73,545
Reconciled Depreciation
1,644
1,644
--
1,847
1,499
Net Income from Continuing Operation Net Minority Interest
-58,241
-58,241
--
-88,222
-75,800
Total Unusual Items Excluding Goodwill
-937
-937
--
--
--
Total Unusual Items
-937
-937
--
--
--
Normalized EBITDA
-57,064
-57,064
--
-87,302
-73,545
12/31/2021 - 10/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RLYB Rallybio Corporation
0.5570
-3.97%
 
INAB IN8bio, Inc.
0.1612
-5.51%
 
IVVD Invivyd, Inc.
0.5500
-5.03%
 
AEON AEON Biopharma, Inc.
0.5315
-1.74%
 
ENTO Entero Therapeutics, Inc.
0.4370
+6.30%
 
IKNA Ikena Oncology, Inc.
1.2000
-4.00%
 
CGTX Cognition Therapeutics, Inc.
0.3860
-6.51%
 
GLUE Monte Rosa Therapeutics, Inc.
3.8900
-11.79%
 
LIXT Lixte Biotechnology Holdings, Inc.
1.1850
-2.87%
 
XFOR X4 Pharmaceuticals, Inc.
0.2100
-7.89%